In Q1 2026, Abbott Laboratories reported a modest earnings beat, closed its US$21.00 billion Exact Sciences acquisition to expand in cancer diagnostics, and outlined a new volume-led Nutrition strategy after a 6% sales decline, while continuing to face significant infant formula litigation and regulatory scrutiny. These developments have prompted analysts and commentators to reassess Abbott’s execution risks and diversification benefits, balancing dilution from the Exact Sciences deal…
Is Abbott’s Exact Sciences Deal And Nutrition Pivot Altering The Investment Case For Abbott (ABT)?
Latest from Blog
Mayor Bissen signs County Food and Nutrition Security Plan into law
Mayor Richard Bissen signed Bill 98 into law yesterday, codifying the Maui County Food and Nutrition Security Plan and establishing a long-term framework to strengthen food security and Maui County’s local food
Should You Stop Buying Shredded Cheese? What Nutrition Experts Say
Here’s why those tiny pieces of cheddar or mozzarella don’t clump together. Post Views: 0
Consumer Reports’ Highest-Rated Non-Dairy Milk Is Almost As Nutritious As Cow’s Milk
According to Consumer Reports, the plant-based milk alternative that’s the closest to dairy milk nutritionally is Silk Unsweet Organic Soymilk. Post Views: 0
Is There Really A Healthiest Cooking Oil?
Post Views: 0
As Food Safety Act deadline looms, these additives will be phased out
What to know about the upcoming “Skittles ban” implementation, according to nutrition columnist LeeAnn Weintraub. Post Views: 0